IGF1 and neoplasm: However, aberrations of this molecular pathway such as overexpression of IGF1R, elevated plasma levels of IGF1, loss of IGF2 imprinting, or genetic polymorphisms of the gene encoding IGF1 have been found in many cancers, affecting multiple aspects of malignancy such as tumor growth and metastases [3,4].